MEDLINE Journals

    Transvenous internal cardioversion for atrial fibrillation: a randomized comparison between catheters with different coil length.

    Authors
    Boriani G, Biffi M, Camanini C, et al. 
    Institution

    Institute of Cardiology, University of Bologna, Azienda Ospedaliera S. Orsola-Malpighi, Bologna, Italy. cardio1@almadns.unibo.it

    Source
    Am Heart J 2002 Nov; 144(5) :851-7.
    Abstract

    The aim of this study was to evaluate the effects of 2 different right atrial electrode coil lengths on energy and voltage requirements for transvenous atrial cardioversion.Twenty-six patients (mean age 61 +/- 11 years) with chronic persistent atrial fibrillation (AF) (mean duration 11 +/- 10 months) underwent transvenous cardioversion. A 6F catheter with a 5.5-cm coil was positioned in the coronary sinus. Another catheter with either a 5.5-cm or an 8-cm coil was positioned along the lateral wall of the right atrium, according to a randomized allocation. R wave-synchronized biphasic shocks were delivered according to a step-up protocol. After cardioversion of baseline AF, AF was reinduced, the right atrial catheter was substituted, and cardioversion was repeated with the alternative right atrial coil.Successful cardioversion was obtained in all of the patients. Leading edge voltage of effective shocks was significantly lower when catheters with an 8-cm coil in right atrium were used compared with the alternative 5-cm coil catheters (301 +/- 80 volts vs 340 +/- 78 volts, P <.001), and delivered energy (6.75 +/- 4.25 joules vs 7.86 +/- 4.29 joules, P =.043) and shock impedance (60 +/- 9 ohm vs 66 +/- 10 ohm, P <.001) were lower. Moreover, shock-induced discomfort, evaluated by assessment of pain score, was reduced (3.69 +/- 1.09 vs 4.12 +/- 0.99, P =.035).The use of a longer right atrial coil results in lower shock impedance, lower energy and voltage requirements, and lower discomfort during transvenous atrial cardioversion. The results of the current study are of value either for transvenous internal cardioversion of chronic persistent AF or for implantable atrial defibrillators.

    Mesh
    Adult
    Aged
    Atrial Fibrillation
    Chronic Disease
    Defibrillators, Implantable
    Electric Countershock
    Equipment Design
    Female
    Humans
    Male
    Middle Aged
    Language

    eng

    Pub Type(s)
    Clinical Trial Journal Article Randomized Controlled Trial
    PubMed ID

    12422155

    Content Manager
    Related Content

    Transvenous internal cardioversion for atrial fibrillation: a randomized study on defibrillation threshold and tolerability of asymmetrical compared with symmetrical shocks.

    Safety and efficacy of low-energy cardioversion of 500 patients using two different techniques.

    Clinical shock tolerability and effect of different right atrial electrode locations on efficacy of low energy human transvenous atrial defibrillation using an implantable lead system.

    Low-energy transvenous cardioversion of atrial fibrillation using a single atrial lead system.

    Low-energy cardioversion of spontaneous atrial fibrillation. Immediate and long-term results.

    Internal cardioversion of chronic atrial fibrillation in patients.

    Transvenous cardioversion of atrial fibrillation using low-energy shocks.

    Favorable effects of flecainide in transvenous internal cardioversion of atrial fibrillation.